Human lactational response to oral thyrotropin releasing hormone
Author
dc.contributor.author
Tyson, J. E.
Author
dc.contributor.author
Perez, A.
Author
dc.contributor.author
Zanartu, J.
Admission date
dc.date.accessioned
2019-01-29T15:46:01Z
Available date
dc.date.available
2019-01-29T15:46:01Z
Publication date
dc.date.issued
1976
Cita de ítem
dc.identifier.citation
Journal of Clinical Endocrinology and Metabolism, Volumen 43, Issue 4, 2018, Pages 760-768
Identifier
dc.identifier.issn
19457197
Identifier
dc.identifier.issn
0021972X
Identifier
dc.identifier.other
10.1210/jcem-43-4-760
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162306
Abstract
dc.description.abstract
Several studies were designed to evaluate the effect of oral TRH on prolactin (PRL) secretion and mammary function in nursing women. Initially, efficacy was studied in nursing women following 5 mg TRH. PRL levels rose to a mean maximum of 46.3 ng/ml above baseline at 60 min. Plasma TSH also increased from a mean baseline of 2.6 to 17.6 /µU/ml at 180 min. No changes were observed following placebo. In order to observe the long term effects of oral TRH, two groups of women in full nursing were studied. Beginning on day 29 postpartum, either 5 mg TRH or placebo were taken twice daily for four weeks. No chronic elevations were observed in maternal PRL and TSH or in infant TSH before or after one month of either regimen. Milk composition expressed in terms of per cent protein and per cent fat did not differ between the groups. Weekly gonadotropin levels were also similar as were infant weight gain and growth. In a group of women with lactational insufficiency receiving 5-20 mg TRH twice dai